Top Markets
#1 DogBull DogBull +54.40%
#2 Siren Siren +31.81%
#3 OriginTrail OriginTrail +15.19%
#4 Verus Coin Verus Coin +11.30%
#5 Tutorial Tutorial +8.83%
#6 Yield Basis Yield Basis +8.48%
#7 Prom Prom +8.33%
#8 Falcon Finance Falcon Finance +7.80%
#9 COTI COTI +7.42%
#10 Stargate Finance Stargate Finance +6.97%
Coin of the day
DogBull DogBull
Cài đặt
Ngôn ngữ
TIếNG VIệT
Tiền tệ
USD
Chủ đề
Acrivon Therapeutics, Inc. Common Stock Acrivon Therapeutics, Inc. Common Stock

Acrivon Therapeutics, Inc. Common Stock

ACRV
Xếp hạng trong cổ phiếu #22054
Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Acrivon Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company primarily focused on creating oncology treatments. The firm employs a unique strategy to identify patients whose tumors are predicted to be sensitive to specific medications, utilizing its proprietary proteomics-based platform for patient identification. This advanced system, named Acrivon Predictive Precision Proteomics (AP3), serves as a precision medicine tool. It is instrumental in developing drug-specific OncoSignature companion diagnostics, which are designed to pinpoint individuals most likely to benefit from the company's therapeutic candidates. Acrivon's flagship clinical asset is ACR-368, a selective small molecule inhibitor that targets both CHK1 and CHK2. This candidate is currently undergoing a potentially pivotal Phase 2 trial for a range of advanced tumor types, notably including platinum-resistant ovarian, endometrial, and bladder cancers. Beyond its lead program, the company is also cultivating several early-stage pipeline programs. These initiatives concentrate on crucial regulatory points within the DNA damage response and cell cycle regulation pathways, specifically identifying targets such as the protein kinases WEE1 and PKMYT1. Established in 2018, Acrivon Therapeutics, Inc. maintains its headquarters in Watertown, Massachusetts.
Giá cổ phiếu
$2.23
Đồng bộ lần cuối: 2026-08-21
Vốn hóa thị trường
$95.23M
Thay đổi (1 ngày)
1.14%
Thay đổi (1 năm)
63.60%
Quốc gia
US
Giao dịch Acrivon Therapeutics, Inc. Common Stock (ACRV)

Danh mục

Healthcare
Lịch sử giá cổ phiếu của Acrivon Therapeutics, Inc. Common Stock (ACRV)
Giá đóng cửa cao nhất: $1.94 vào 2026-08-01

Giá đóng cửa thấp nhất: $13.89 vào 2022-11-01
Lịch sử giá cổ phiếu của Acrivon Therapeutics, Inc. Common Stock từ 2022 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2026 (TTM) -23.66%
2025 -63.95%
2024 34.00%
2023 -58.79%
2022 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH